carbodiimides has been researched along with Allergic Encephalomyelitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miller, SD; Turley, DM | 2 |
1 review(s) available for carbodiimides and Allergic Encephalomyelitis
| Article | Year |
|---|---|
Prospects for antigen-specific tolerance based therapies for the treatment of multiple sclerosis.
Topics: Animals; Antibodies, Monoclonal; Autoantigens; Autoimmunity; Carbodiimides; CD4-Positive T-Lymphocytes; Encephalomyelitis, Autoimmune, Experimental; Humans; Immunity, Mucosal; Immunosuppression Therapy; Mice; Multiple Sclerosis; Peptides; Receptors, Antigen, T-Cell; Self Tolerance; T-Lymphocytes, Regulatory | 2010 |
1 other study(ies) available for carbodiimides and Allergic Encephalomyelitis
| Article | Year |
|---|---|
Peripheral tolerance induction using ethylenecarbodiimide-fixed APCs uses both direct and indirect mechanisms of antigen presentation for prevention of experimental autoimmune encephalomyelitis.
Topics: Animals; Antigen Presentation; Antigen-Presenting Cells; Apoptosis; Autoantigens; Carbodiimides; CD4-Positive T-Lymphocytes; Cell Communication; Cells, Cultured; Encephalomyelitis, Autoimmune, Experimental; Fixatives; Histocompatibility Antigens Class II; Immune Tolerance; Mice; Mice, Inbred BALB C; Transplantation, Homologous; Transplantation, Isogeneic | 2007 |